1Zpes DP, Camm A J, Borggrefe M, et al, ACC/AHA/ESC 2006guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death executive summary : A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committe for Practice Guidelines [J]. Circulation, 2006, 114 : 1099.
4Mehvar R, Brocks DR. Stereospecific Pharmacokinetics and Pharmacodynamics of Beta-Adrenergic Blockers in Humans [J]. Pharm Pharmceut Sci, 2001,4(2) : 186-190.
5EscuderoC, Carr R, Sanatani S. Overview of antiarrhythmic drug therapy for supraventricular tachycardia in children [J]. Progress in Pediatric Cardiology, 2013, 35: 56-59.
7Myles RC, Wang LG, Kang CY, et al. Local beta-adrenergic stimulation overcomes source-sink mismatch to generate focal arrhythmia [J]. Circ Res, 2012, 110(11): 1454-1464.
9Chen WR, Shi XM, Yang TS, et al. Protective effect of metoprolol on arrhythmia and heart rate variability in healthy people with 24 hours of sleep deprivation [J]. J Interv Card Electrophysiol, 2013, 36: 267-272.
10He WB, Lu ZB, Bao MW, et al. Autonomic involvement in idiopathic premature ventricular contractions [J]. Clin Res Cardiol, 2013, 102: 361-370.
8Olshansky B, Rosenfeld LE, Warner AL, et al. The atrial fibrillation follow-up investigation of thythm management (AFFITM) study: approaches to control rate in atrial fibrillation [ J ]. J Am Coll Cardiol, 2004,43(7) : 1201-1208.
9Clemo HF, Wood MA, Gilligan DM, et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias[J]. Am J Cardiol, 1998,81 (5) :594-598.
10Valentin F, Lars ER, David SC, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary [J]. J Am Coll Cardiol,2006,48(4):854-906.
